QUEBEC CITY — Treating patients with established cardiovascular disease (CVD) or other high-risk factors for CV events with icosapent ethyl (IPE) may help reduce the risk for days lost to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback